Haploidentical Stem Cell Transplantation in Neuroblastoma
This study is ongoing, but not recruiting participants.
Lund University Hospital
First Posted: November 13, 2008
Last Update Posted: March 14, 2017
Information provided by (Responsible Party):
Jacek Toporski, Lund University Hospital
No Study Results Posted on ClinicalTrials.gov for this Study
|Study Status:||This study is ongoing, but not recruiting participants.|
|Study Completion Date:||No date given|
|Estimated Primary Completion Date:||December 2018 (Final data collection date for primary outcome measure)|
Toporski J, Garkavij M, Tennvall J, Ora I, Gleisner KS, Dykes JH, Lenhoff S, Juliusson G, Scheding S, Turkiewicz D, Békássy AN. High-dose iodine-131-metaiodobenzylguanidine with haploidentical stem cell transplantation and posttransplant immunotherapy in children with relapsed/refractory neuroblastoma. Biol Blood Marrow Transplant. 2009 Sep;15(9):1077-85. doi: 10.1016/j.bbmt.2009.05.007. Epub 2009 Jul 8.